Oragenics' (OGEN) Q3 2023 EPS forecast of -$1.41 is significantly lower than the EPS of the previous quarter, Q2 2023, which was $2.3% higher at $0.181. This indicates a potential decline in the company's financial performance, which may be a concern for investors.